McLean Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
McLean Asset Management's PFE Position: Q1 2026 in Review
McLean Asset Management increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $28K and bringing the position to 8,915 shares worth $250K. The position accounts for 0.04% of the portfolio, ranked #148.
McLean Asset Management first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $769K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- McLean Asset Management held 8,915 shares of Pfizer worth $250K as of Q1 2026.
- McLean Asset Management bought 1,050 Pfizer shares in Q1 2026, an estimated $28K.
- Pfizer made up 0.04% of McLean Asset Management's portfolio in Q1 2026, its #148 holding.
- McLean Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
- McLean Asset Management's Pfizer position peaked at $769K in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.